본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
()

Jeon Jin Young
(Department of Phamacy Administration)
. Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis. THROMBOSIS JOURNAL. 2023-07-14; 2023; 21(1):76~. IF 3.1 (2022)
Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigation
()

Dho Yun Sik
(Department of Neurosurgery)
. Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigation. INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY. 2023-07-13; 2023; 19(1):15~25. IF 3 (2022)
(Grant 수정 필요)Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance Park Charny
(Bioinformatics Branch)

Kim, Sun Shin
(Targeted Therapy Branch)
. (Grant 수정 필요)Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance. CANCERS. 2023-07-11; 2023; 15(14):3568~. IF 5.2 (2022)
Myelomeningocele: The Evolution of Care over the last 50 years Wang Kyu Chang
(Department of Neurosurgery)


()
. Myelomeningocele: The Evolution of Care over the last 50 years. CHILDS NERVOUS SYSTEM. 2023-07-07; 2023; 39(10):2829~2845. IF 1.4 (2022)
(Grant 수정 요청)Is Fragmented Cancer Care Associated With Medical Expenditures? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data
()

Han Kyu Tae
(Division of Cancer Management Policy)
. (Grant 수정 요청)Is Fragmented Cancer Care Associated With Medical Expenditures? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data. INTERNATIONAL JOURNAL OF PUBLIC HEALTH. 2023-07-06; 2023; 68:1606000~. IF 4.6 (2022)
Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists Park Hyeon Jin
(Department of Pediatrics)


()
. Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists. JOURNAL OF KOREAN MEDICAL SCIENCE. 2023-07-05; 2023; 38(29):e230~. IF 4.5 (2022)
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study LEE, BYUNG IL
(Targeted Therapy Branch)


(Department of Cancer Biomedical Science)
. Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study. SCIENTIFIC REPORTS. 2023-07-04; 2023; 13(1):10805~. IF 4.6 (2022)
(grant 수정 필요)NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling Lee Ho
(Department of Cancer Biomedical Science)

Park Mi Kyung
(Department of Cancer Biomedical Science)
. (grant 수정 필요)NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling. CANCER RESEARCH. 2023-07-03; 2023; 83(18):3045~3058. IF 11.2 (2022)
Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients Kim Haksoo
(Department of Radiation oncology)

Cheon Won Joong
(Center for Proton Therapy)
. Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients. CANCERS. 2023-07-02; 2023; 15(13):3463~. IF 5.2 (2022)
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) Hyeon-Seok Eom
(Hospital)


()
. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). ANNALS OF HEMATOLOGY. 2023-07-01; 2023; 102(8):2233~2240. IF 3.5 (2022)
First page Prev paging 11 12 13 14 15 16 17 18 19 20 next paging last page